StockData
STERIS plc logo

STERIS plc (STE) stock

STENYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends March 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 19/300% above fair value
$257.41−4.50 (-1.72%)

Close on Nov 17, 2026Market cap $25.10BP/E 31.5Yield 0.96%

Earnings

Steris's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 3, 2027
Q3 FY2027 · estimated, after the close
Revenue, Q2 FY2027
$1.60B
+6.7% on a year earlier
adjusted EPS, Q2 FY2027
$2.94
$2.47 a year earlier
Latest guidance
Issued
Nov 4, 2026 · 6 items

Quarterly results

Revenue and earnings per share from each of Steris's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q3 FY2027ended Dec 31, 2026Feb 3, 2027Expected–––––
Q2 FY2027ended Sep 30, 2026Nov 4, 2026after the close$1.60B+6.7%$2.19$2.94Release
Q1 FY2027ended Jun 30, 2026Aug 5, 2026after the close$1.50B+7.1%$2.04$2.59Release
Q4 FY2026ended Mar 31, 2026May 11, 2026after the close$1.60B+6.7%$2.24$2.83Release
Q3 FY2026ended Dec 31, 2025Feb 4, 2026after the close$1.50B+7.1%$1.96$2.53Release
Q2 FY2026ended Sep 30, 2025Nov 5, 2025after the close$1.50B+15.4%$1.94$2.47Release
Q1 FY2026ended Jun 30, 2025Aug 6, 2025after the close$1.40B+7.7%$1.79$2.34Release
Q4 FY2025ended Mar 31, 2025May 14, 2025after the close$1.50B0.0%$1.48$2.74Release
Q3 FY2025ended Dec 31, 2024Feb 5, 2025after the close$1.40B0.0%$1.75$2.32Release
Q2 FY2025ended Sep 30, 2024Nov 6, 2024after the close$1.30B-3.0%$1.51$2.14Release
Q1 FY2025ended Jun 30, 2024Aug 6, 2024after the close$1.30B+1.6%$1.41$2.03Release
Q4 FY2024ended Mar 31, 2024May 8, 2024after the close$1.50B+8.7%-$0.01$2.58Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Steris's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
as reported revenue growthGAAPFY2027+7% – +8%–NewNov 4, 2026
as reported revenue growthGAAPFY2027+7% – +8%+7% – +8%ReaffirmedAug 5, 2026
constant currency organic revenue growthnon-GAAPFY2027+6% – +7%–NewNov 4, 2026
constant currency organic revenue growthnon-GAAPFY2027+6% – +7%+6% – +7%ReaffirmedAug 5, 2026
Net income from continuing operations per diluted shareGAAPFY2027$8.92 – $9.12–NewNov 4, 2026
Net income from continuing operations per diluted shareGAAPFY2027$8.92 – $9.12$9.00 – $9.20LoweredAug 5, 2026
Adjusted earnings per diluted sharenon-GAAPFY2027$11.35 – $11.55–NewNov 4, 2026
Adjusted earnings per diluted sharenon-GAAPFY2027$11.10 – $11.30$11.10 – $11.30ReaffirmedAug 5, 2026
Free cash flownon-GAAPFY2027$800.00M$850.00MLoweredAug 5, 2026
Free Cash Flownon-GAAPFY2027$800.00M–NewNov 4, 2026
capital expendituresFY2027$450.00M$375.00MRaisedAug 5, 2026
Purchases of property, plant, equipment, and intangiblesGAAPFY2027$450.00M–NewNov 4, 2026
Cash flows from operating activitiesGAAPFY2027$1.25B–NewAug 5, 2026
effective tax rateFY202725%–NewMay 11, 2026

Guidance vs results

The last range Steris gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
FY2026Adjusted earnings per diluted share from continuing operations$10.15 – $10.30$10.17Σ4QWithin range
FY2026EPS (GAAP)$7.97 – $8.12$7.93Σ4QBelow range
FY2026Revenue growth+8% – +9%+9.09%Σ4QAbove range
FY2025Adjusted earnings per diluted share from continuing operations$9.05 – $9.15$9.23Σ4QAbove range
FY2025EPS (GAAP)$6.66 – $6.76$6.15Σ4QBelow range
FY2025Revenue growth+6%-0.36%Σ4QBelow range

Guidance history

Every forecast Steris put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 4, 2026Purchases of property, plant, equipment, and intangiblesFY2027$450.00MNew
Nov 4, 2026Adjusted earnings per diluted shareFY2027$11.35 – $11.55New
Nov 4, 2026Net income from continuing operations per diluted shareFY2027$8.92 – $9.12New
Nov 4, 2026Free Cash FlowFY2027$800.00MNew
Nov 4, 2026as reported revenue growthFY2027+7% – +8%New
Nov 4, 2026constant currency organic revenue growthFY2027+6% – +7%New
Aug 5, 2026capital expendituresFY2027$450.00MRaised
Aug 5, 2026Adjusted earnings per diluted shareFY2027$11.10 – $11.30Reaffirmed
Aug 5, 2026Net income from continuing operations per diluted shareFY2027$8.92 – $9.12Lowered
Aug 5, 2026Free cash flowFY2027$800.00MLowered
Aug 5, 2026Cash flows from operating activitiesFY2027$1.25BNew
Aug 5, 2026as reported revenue growthFY2027+7% – +8%Reaffirmed
Aug 5, 2026constant currency organic revenue growthFY2027+6% – +7%Reaffirmed
May 11, 2026Capital expendituresFY2027$375.00MNew
May 11, 2026Adjusted earnings per diluted shareFY2027$11.10 – $11.30New
May 11, 2026Net income from continuing operations per diluted shareFY2027$9.00 – $9.20New
May 11, 2026free cash flowFY2027$850.00MNew
May 11, 2026effective tax rateFY202725%New
May 11, 2026as reported revenueFY2027+7% – +8%New
May 11, 2026constant currency organic revenue growthFY2027+6% – +7%New

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Steris filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Results
  4. Update
  5. Results
  6. Results
  7. Results
  8. Results
  9. Results
  10. Results
  11. Results
  12. Results
  13. Results
  14. Update
  15. Results

See a number that looks wrong?